Literature DB >> 34283810

Nucleocapsid-specific and PD-L1+CXCR3+ CD8 polyfunctional T-cell abundances are associated with survival of critical SARS-CoV2-infected patients.

Lucille Adam1, Pierre Rosenbaum1, Paul Quentric2, Christophe Parizot2, Olivia Bonduelle1, Noëlline Guillou1, Aurelien Corneau3, Karim Dorgham1, Makoto Miyara2, Charles-Edouard Luyt4, Amélie Guihot1, Guy Gorochov1, Christophe Combadière1, Behazine Combadière1.   

Abstract

RATIONALE: The importance of the adaptative T cell response in the control and resolution of viral infection has been well-established. However, the nature of T cell-mediated viral control mechanisms in life-threatening stages of COVID-19 has yet to be determined.
OBJECTIVE: The aim of the present study was to determine the function and phenotype of T cell populations associated with survival or death of COVID-19 patients under intensive care as a result of phenotypic and functional profiling by mass cytometry.
FINDINGS: Increased frequencies of circulating, polyfunctional, CD4+CXCR5+HLA-DR+ stem cell memory T cells (TSCM) and decreased proportions of Granzyme-B and Perforin-expressing effector memory T cells (TEM) were detected in recovered and deceased patients, respectively. The higher abundance of polyfunctional CD8+PD-L1+CXCR3+ T effector cells, CXCR5+HLA-DR+ TSCM, as well as anti-nucleocapsid (NC) cytokine-producing T cells permitted to differentiate between recovered and deceased patients. The results from a principal component analysis showed an imbalance in the T cell compartment allowed for the separation of recovered and deceased patients. The paucity of circulating CD8+PD-L1+CXCR3+ Teff-cells and NC-specific CD8+ T-cells accurately forecasts fatal disease outcome.
CONCLUSION: This study provides insight into the nature of the T cell populations involved in the control of COVID-19 and therefor might impact T cell-based vaccine designs for this infectious disease.

Entities:  

Keywords:  Adaptive immunity; Immunology; T cells

Year:  2021        PMID: 34283810     DOI: 10.1172/jci.insight.151571

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  3 in total

1.  Preexisting Humoral Immunity Cross-Reacting with SARS-CoV-2 Might Prevent Death Due to COVID-19 in Critical Patients.

Authors:  Taro Yamashita; Tetsuro Shimakami; Kouki Nio; Takeshi Terashima; Masaki Okajima; Takumi Taniguchi; Takashi Wada; Masao Honda; Toshifumi Gabata; Kenji Ota; Katsunori Yanagihara; Shuichi Kaneko
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964

Review 2.  COVID-19 immunopathology: From acute diseases to chronic sequelae.

Authors:  Mohd Arish; Wei Qian; Harish Narasimhan; Jie Sun
Journal:  J Med Virol       Date:  2022-09-03       Impact factor: 20.693

3.  Heterogenous CD8+ T Cell Maturation and 'Polarization' in Acute and Convalescent COVID-19 Patients.

Authors:  Igor V Kudryavtsev; Natalia A Arsentieva; Zoia R Korobova; Dmitry V Isakov; Artem A Rubinstein; Oleg K Batsunov; Irina V Khamitova; Raisa N Kuznetsova; Tikhon V Savin; Tatiana V Akisheva; Oksana V Stanevich; Aleksandra A Lebedeva; Evgeny A Vorobyov; Snejana V Vorobyova; Alexander N Kulikov; Maria A Sharapova; Dmitrii E Pevtsov; Areg A Totolian
Journal:  Viruses       Date:  2022-08-28       Impact factor: 5.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.